Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021 18 8
Fludarabine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 2 0
Bromhexine hydrochloride Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/15/2021 3 1
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021 7 0
Canakinumab Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/19/2021 4 0
Homoharringtonine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/02/2020 3 0
Castanospermine Potential treatment - pre-clinical evidence Natural product Antiviral Nov/16/2020 2 0
Polydatin Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020 3 0
Excel (.xslx) CSV (.csv)